Noema Pharma extends its series B funding to $147M, advancing phase 2 trials for CNS disorders like Tourette syndrome, ...

Is the key to curing the world’s most challenging diseases hidden in unlocking the power of fragmented biological data?

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...

As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...

Radiopharmaceuticals have also been the target of large partnership deals, including a recent $140 million partnership ...

Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...

Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...